Pasha Sarraf's most recent trade in Cue Biopharma Inc was a trade of 24,400 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cue Biopharma Inc | Pasha Sarraf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 24,400 | 24,400 | - | - | Stock Option (right to buy) | |
| Cue Biopharma Inc | Pasha Sarraf | Director | Purchase of securities on an exchange or from another person at price $ 0.32 per share. | 30 Dec 2025 | 86,947 | 168,324 (0%) | 0% | 0.3 | 27,597 | Common Stock |
| Cue Biopharma Inc | Sarraf Pasha | Director | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 30 Dec 2025 | 78,116 | 246,440 (1%) | 0% | 0.3 | 24,325 | Common Stock |
| Cue Biopharma Inc | Sarraf Pasha | Director | Purchase of securities on an exchange or from another person at price $ 0.30 per share. | 30 Dec 2025 | 77,417 | 323,857 (1%) | 0% | 0.3 | 23,349 | Common Stock |
| Cue Biopharma Inc | Sarraf Pasha | Director | Purchase of securities on an exchange or from another person at price $ 0.30 per share. | 30 Dec 2025 | 77,148 | 81,377 (0%) | 0% | 0.3 | 23,168 | Common Stock |
| Cue Biopharma Inc | Pasha Sarraf | Director | Purchase of securities on an exchange or from another person at price $ 0.31 per share. | 30 Dec 2025 | 4,229 | 4,229 (0%) | 0% | 0.3 | 1,308 | Common Stock |
| Cue Biopharma Inc | Pasha Sarraf | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Mar 2025 | 48,800 | 48,800 | - | - | Stock Option (right to buy) |